Table 2 Incidence rate and adjusted hazard ratio of clinical outcomes in entire population.
N, (%) | ARB group (N = 298) | ACEI group (N = 900) | Hazard Ratio (95% CI) | p-value |
|---|---|---|---|---|
4-year follow up | ||||
MACCE | 29 (9.7) | 101 (11.2) | 0.69 (0.44–1.06) | 0.09 |
Total death | 12 (4.0) | 26 (2.9) | 0.57 (0.25–1.30) | 0.71 |
Cardiac death | 4 (1.3) | 8 (0.9) | 1.48 (0.39–5.73) | 0.57 |
MI | 5 (1.7) | 12 (1.3) | 0.80 (0.26–2.50) | 0.7 |
Re-revascularization | 7 (2.3) | 37 (4.1) | 1.15 (0.54–2.46) | 0.18 |
Stroke | 10 (3.4) | 38 (4.2) | 0.57 (0.28–1.19) | 0.14 |
Heart failure | 156 (52.3) | 384 (42.7) | 0.80 (0.26–2.50) | 0.11 |
Graft failure | 7 (2.3) | 28 (3.1) | 0.57 (0.25–1.30) | 0.92 |
1-year follow up | ||||
MACCE | 13 (4.4) | 73 (8.1) | 0.49 (0.27–0.91) | 0.02 |
Total death | 4 (1.3) | 9 (1.0) | 1.42 (0.38–5.33) | 0.6 |
Cardiac death | 3 (1.0) | 3 (0.3) | 5.55 (0.75–41.0) | 0.09 |
MI | 1 (0.3) | 8 (0.9) | 0.29 (0.03–2.52) | 0.26 |
Re-revascularization | 3 (1.0) | 28 (3.1) | 0.36 (0.11–0.20) | 0.1 |
Stroke | 5 (1.7) | 32 (3.6) | 0.41 (0.15–1.07) | 0.07 |
Heart failure | 3 (1.0) | 1 (0.1) | 32.43 (0.94–1122.4) | 0.05 |
Graft failure | 7 (2.3) | 17 (1.9) | 1.61 (0.64–4.04) | 0.31 |
